5 Stanley Druckenmiller Recursion Pharmaceuticals Trades
Stanley Druckenmiller started to build up the position in Recursion Pharmaceuticals in Q3 2021 and continued to invest until Q3 2022. Since then they sold 1.39M shares. The investor completely sold their stake between Q3 2023 and Q1 2024.
Avg closing price
Price range
Sold -907k shares
Q1 2024
Avg closing price
$11.14
Price range
$9.13
-
$15.52
Sold 34.6% shares (-479k shares)
Q3 2023
Avg closing price
$9.98
Price range
$6.59
-
$15.86
Increased shares by 406.5% (+1.11M shares)
Q3 2022